B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $36

Benzinga Newsdesk www.benzinga.com Neutral 55.3%

Neg 0% Neu 55.3% Pos 0%

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $25 to $36.